Home / Private raises / INFLAMMATIX, INC.
INFLAMMATIX, INC.
Biotechnology · Sunnyvale, California · $47.4M sold across 1 offering
Form D filings (1)
| Filed | Form | Sold | Offered | Investors | Exemption | Securities | First sale | |
|---|---|---|---|---|---|---|---|---|
| 2026-11-19 | D (new) | $47.4M | $57.3M | 14 | 506(b) | Equity, Options/warrants, Security to be acquired, Offer and sale of Series E and E-1 Preferred Stock and Common Stock issuable upon conversion thereof. Certain exchanged Common Stock were issued for shares of a specific series of Preferred Stock. Warrants to purchase Series E-2 Preferred Stock. | Apr 5 | SEC ↗ |
An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.
Issuer
| Industry | Biotechnology |
| Located | Sunnyvale, California |
| Entity | Corporation |
| Incorporated | Delaware |
| SEC CIK | 1801477 |
People named in the latest filing
| Name | Role |
|---|---|
| TIMOTHY E. SWEENEY | Executive Officer, Director |
| HEINER DREISMANN | Director |
| FLORIAN KAINZINGER | Director |
| INGO CHAKRAVARTY | Director |
| STEVEN TABLAK | Director |
| JONATHAN ROMANOWSKY | Director |
| DAVID PERSING | Director |
Names and roles as filed with the SEC. Addresses are not shown.
Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.
How are we doing?
